Rapamycin inhibits GM-CSF-induced neutrophil migration

Area of Science:

• Immunology and Cell Biology
• Molecular Biology
• Pharmacology

Background:

• Cell migration is crucial for biological and medical processes, including immune responses and tissue repair.
• Understanding the molecular pathways governing cell movement is essential for developing targeted therapies.

Purpose of the Study:

• To investigate the effect of rapamycin, an mTOR inhibitor, on leukocyte chemotaxis and chemokinesis.
• To elucidate the role of the mammalian target of rapamycin (mTOR)/ribosomal p70-S6 kinase (p70S6K) pathway in neutrophil migration.

Main Methods:

• Utilized rapamycin and FK506 to inhibit the mTOR/p70S6K pathway in neutrophils.
• Stimulated neutrophils with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-8 (IL-8).
• Assessed chemotaxis and chemokinesis inhibition, p70S6K phosphorylation, and actin polymerization.

Main Results:

• Rapamycin significantly inhibited neutrophil chemotaxis and chemokinesis induced by GM-CSF (IC(50) = 0.3 nM) and IL-8.
• Rapamycin blocked GM-CSF-induced p70S6K phosphorylation and actin polymerization.
• The mTOR/S6K pathway is critical for GM-CSF-induced neutrophil migration, as evidenced by rapamycin's potent inhibitory effects.

Conclusions:

• Rapamycin effectively inhibits leukocyte chemotaxis and chemokinesis at sub-nanomolar concentrations.
• The mammalian target of rapamycin (mTOR)/ribosomal p70-S6 kinase (p70S6K) pathway plays a vital role in neutrophil migration.
• These findings underscore the therapeutic potential of targeting the mTOR/S6K pathway in inflammatory and immune-related diseases.